Skip to content
10-Q

Quarterly Report

Aclaris Therapeutics, Inc. ACRS

0001558370-25-010789

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 31, 2025 108.33M sh
Shares Diluted Q2 2025 · Jun 30, 2025 122.58M sh
Shares Diluted Q2 2025 · Jun 30, 2025 122.49M sh
Shares Diluted Q2 2025 · Jun 30, 2024 71.29M sh
Shares Diluted Q2 2025 · Jun 30, 2024 71.18M sh
Capex Q2 2025 · Jun 30, 2025 $64K
Capex Q2 2025 · Jun 30, 2024 $121K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$23.05M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$33.14M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $25.4M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $24.57M
Stockholders Equity Q2 2025 · Jun 30, 2025 $131.74M
Stockholders Equity Q2 2025 · Mar 31, 2025 $144.07M
Stockholders Equity Q2 2025 · Dec 31, 2024 $155.55M
Stockholders Equity Q2 2025 · Jun 30, 2024 $133.82M
Stockholders Equity Q2 2025 · Mar 31, 2024 $142.01M
Stockholders Equity Q2 2025 · Dec 31, 2023 $157.18M
Current Liabilities Q2 2025 · Jun 30, 2025 $26.84M
Current Liabilities Q2 2025 · Dec 31, 2024 $31.6M
Total Liabilities Q2 2025 · Jun 30, 2025 $57.41M
Total Liabilities Q2 2025 · Dec 31, 2024 $64.77M
Current Assets Q2 2025 · Jun 30, 2025 $104.2M
Current Assets Q2 2025 · Dec 31, 2024 $125.95M
Total Assets Q2 2025 · Jun 30, 2025 $189.15M
Total Assets Q2 2025 · Dec 31, 2024 $220.33M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.13
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.25
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.15
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.39
Eps Basic Q2 2025 · Jun 30, 2025 −$0.13
Eps Basic Q2 2025 · Jun 30, 2025 −$0.25
Eps Basic Q2 2025 · Jun 30, 2024 −$0.15
Eps Basic Q2 2025 · Jun 30, 2024 −$0.39
Sga Expense Q2 2025 · Jun 30, 2025 $5.39M
Sga Expense Q2 2025 · Jun 30, 2025 $11.53M
Sga Expense Q2 2025 · Jun 30, 2024 $4.75M
Sga Expense Q2 2025 · Jun 30, 2024 $11.6M
Rd Expense Q2 2025 · Jun 30, 2025 $11.45M
Rd Expense Q2 2025 · Jun 30, 2025 $23.03M
Rd Expense Q2 2025 · Jun 30, 2024 $8.76M
Rd Expense Q2 2025 · Jun 30, 2024 $18.6M
Net Income Q2 2025 · Jun 30, 2025 −$15.43M
Net Income Q2 2025 · Jun 30, 2025 −$30.51M
Net Income Q2 2025 · Mar 31, 2025 −$15.09M
Net Income Q2 2025 · Jun 30, 2024 −$10.99M
Net Income Q2 2025 · Jun 30, 2024 −$27.93M
Net Income Q2 2025 · Mar 31, 2024 −$16.94M
Operating Income Q2 2025 · Jun 30, 2025 −$18.41M
Operating Income Q2 2025 · Jun 30, 2025 −$36.49M
Operating Income Q2 2025 · Jun 30, 2024 −$12.85M
Operating Income Q2 2025 · Jun 30, 2024 −$31.79M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $515K
Cost Of Revenue Q2 2025 · Jun 30, 2025 $1.02M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $624K
Cost Of Revenue Q2 2025 · Jun 30, 2024 $1.43M
Revenue Q2 2025 · Jun 30, 2025 $1.78M
Revenue Q2 2025 · Jun 30, 2025 $3.23M
Revenue Q2 2025 · Jun 30, 2024 $2.77M
Revenue Q2 2025 · Jun 30, 2024 $5.16M